Schäfer S, Kantartzis K, Machann J, Venter C, Niess A, Schick F, Machicao F, Häring H-U, Fritsche A, Stefan N
Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany.
Eur J Clin Invest. 2007 Jul;37(7):535-43. doi: 10.1111/j.1365-2362.2007.01820.x.
Lifestyle intervention is effective in the prevention of type 2 diabetes in individuals with impaired glucose tolerance (IGT). It is currently unknown whether it has beneficial effects on metabolism to a similar extent, in individuals with normal glucose tolerance (NGT) compared to individuals with IGT.
Data from 181 subjects (133 with NGT and at risk for type 2 diabetes and 48 with IGT) who participated in the Tuebingen Lifestyle Intervention Program with increase in physical activity and decrease in caloric intake were included into this study. Body fat distribution was quantified by whole-body magnetic resonance (MR) tomography and liver fat and intramyocellular fat by (1)H-MR spectroscopy. Insulin sensitivity was estimated from an oral glucose tolerance test (OGTT).
After 9 +/- 2 months of follow-up, the diagnosis of IGT was reversed in 24 out of 48 individuals. Only 14 out of 133 participants with NGT developed IGT. Body weight decreased in both groups by 3% (both P < 0.0001). Two-hour glucose concentrations during an OGTT decreased in individuals with IGT (-14%, P < 0.0001) but not with NGT (+2%, P = 0.66). Insulin sensitivity increased both in individuals with IGT (+9%, P = 0.04) and NGT (+17%, P < 0.0001). Visceral fat (-8%, P = 0.006), liver fat (-28%, P < 0.0001) and intramyocellular fat (-15%, P = 0.006) decreased in participants with IGT. In participants with NGT these changes were significant for visceral fat (-16%, P < 0.0001) and liver fat (-35%, P < 0.0001).
Moderate weight loss under a lifestyle intervention with reduction in total, visceral and ectopic fat and increase in insulin sensitivity improves glucose tolerance in individuals with IGT but not with NGT. In individuals with NGT, the beneficial effects of a lifestyle intervention on fat distribution and insulin sensitivity possibly prevent future deterioration in glucose tolerance.
生活方式干预对于糖耐量受损(IGT)个体预防2型糖尿病有效。目前尚不清楚与IGT个体相比,该干预措施对糖耐量正常(NGT)个体的代谢是否具有同样程度的有益影响。
本研究纳入了181名受试者的数据(133名NGT且有2型糖尿病风险者和48名IGT者),这些受试者参加了图宾根生活方式干预项目,该项目包括增加体力活动和减少热量摄入。通过全身磁共振(MR)断层扫描对体脂分布进行量化,通过氢质子磁共振波谱(1H-MR)对肝脏脂肪和肌内脂肪进行量化。根据口服葡萄糖耐量试验(OGTT)评估胰岛素敏感性。
经过9±2个月的随访,48名IGT个体中有24名IGT诊断被逆转。133名NGT参与者中只有14名发展为IGT。两组体重均下降了3%(P均<0.0001)。IGT个体OGTT期间的两小时血糖浓度下降(-14%,P<0.0001),而NGT个体则未下降(+2%,P=0.66)。IGT个体(+9%,P=0.04)和NGT个体(+17%,P<0.0001)的胰岛素敏感性均增加。IGT参与者的内脏脂肪(-8%,P=0.006)、肝脏脂肪(-28%,P<0.0001)和肌内脂肪(-15%,P=0.006)减少。在NGT参与者中,这些变化在内脏脂肪(-16%,P<0.0001)和肝脏脂肪(-35%,P<0.0001)方面具有显著性。
在生活方式干预下适度减重,减少总体脂肪、内脏脂肪和异位脂肪并提高胰岛素敏感性,可改善IGT个体的糖耐量,但对NGT个体无效。在NGT个体中,生活方式干预对脂肪分布和胰岛素敏感性的有益影响可能会预防未来糖耐量的恶化。